Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(19):1480; doi:10.1093/jnci/djh294
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Parker, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parker, C. C.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

Re: Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer

Christopher C. Parker

Correspondence to: Christopher C. Parker, BA, MRCP, MD, FRCR, Academic Unit of Radiotherapy and Oncology, Institute of Cancer Research, Downs Road, Sutton, Surrey SM2 5PT, U.K. (e-mail: Chris.Parker@icr.ac.uk)

The first 10% of the full text of this article appears below.

I was interested to read the updated results of the Zoledronic Acid Prostate Cancer Study Group’s randomized placebo-controlled trial in men with bone metastases from hormone-refractory prostate cancer (HRPC) (1). This was a positive trial, in the sense that zoledronic acid demonstrated statistically significant reductions in skeletal complications. However, there are several reasons . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer
Fred Saad
J Natl Cancer Inst 2004 96: 1480-1481. [Extract] [Full Text] [PDF]